The global adhesion barrier market was valued at $761.0 million in 2015 and it is expected to grow at a CAGR of 8.5% during the period 2016 – 2022. The adhesion barrier market is growing due to increasing geriatric population, increase in volume of surgeries and increasing sports related injuries.
Among the type of product, synthetic adhesion barrier product accounted for the largest share in the global market in 2015, and it is expected to witness 8.6% CAGR during 2016 – 2022. Among the various applications, gynecological surgeries segment is expected to witness the fastest growth during the forecast period.
Geographically, North America has been globally the largest market of adhesion barriers, owing to the growing cases of abdominal problems, neurological diseases and cardiovascular diseases in the region. However, the adhesion barrier market is expected to witness fastest growth in Asia-Pacific, with a CAGR of 8.8% during the period 2016– 2022. The high growth is attributed to increasing awareness about adhesion barriers, improvements in healthcare infrastructure, and rising disposable income in the region.
Some of the key companies operating in the global adhesion barrier market include Medtronic plc, Baxter International Inc., Johnson & Johnson, Sanofi Group, C. R. Bard Inc., MAST Biosurgery AG, Getinge AB, Anika Therapeutics Inc., FzioMed, Inc. and Integra LifeSciences Corporation.
News Courtesy : P&S Market Research